The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Actraphane

percent volume/volume Solution for injection

Novo Nordisk A/SEU/1/02/229/001-035

Main Information

Trade NameActraphane
Active SubstancesInsulin human
Strength percent volume/volume
Dosage FormSolution for injection
Licence HolderNovo Nordisk A/S
Licence NumberEU/1/02/229/001-035

Group Information

ATC CodeA10AD Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting
A10AD01 insulin (human)

Status

Authorised/WithdrawnAuthorised
Licence Issued07/10/2002
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing Status

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back